PolymarketComprobar disponibilidadSin KYC2% de comisiónDatos de resolución verificadosBien calibradoProbabilidad implícita actual
No 94.1%
Calidad del mercado
67 / 100
Calidad mediaVolumen 24h
14,5 €
Liquidez
32,2 mil €
Alta liquidezCompra / Venta
5.0% / 6.0%
Spread
1.0 pt
Spread estrechoComentarios
7
Datos de mercado
Actualizado hace 7 minutos
4 may 26, 14:41 UTC1 ene 27, 4:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will a Hantavirus Vaccine be created in 2026? [Polymarket]
Manifold MarketsHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiHantavirus pandemic in 2026?
Manifold MarketsHantavirus pandemic in 2026? [Polymarket]
Manifold MarketsWill the CDC weaken vaccine recommendation against _____ for children and adolescents in 2026?
FutuurReglas
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Mercados abiertos
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Volumen total
- 15,6 M €
- Volumen 24h
- 30,4 mil €
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volumen total
- 652,8 mil €
- Volumen 24h
- 3,5 mil €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes-0.7pt3%
- Volumen total
- 1,6 M €
- Volumen 24h
- 2,9 mil €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 4000+1.0pt97%
- Above 600059%
+2 resultados más
- Volumen total
- 865,3 mil €
- Volumen 24h
- 2,7 mil €
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Volumen total
- 915,3 mil €
- Volumen 24h
- 1,4 mil €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+1.0pt65%
- September41%
- June28%
- Volumen total
- 84 mil €
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de Hantavirus vaccine in 2026??
- Polymarket cotiza No al 94% a fecha de 9 de septiembre de 2026.
- ¿Cuándo se resuelve Hantavirus vaccine in 2026??
- Está previsto que Hantavirus vaccine in 2026? se resuelva el 1 de enero de 2027.
- ¿Cómo se liquida Hantavirus vaccine in 2026??
- Polymarket liquida este mercado del siguiente modo: This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.